QuickView for Tyrosine-protein kinase, receptor class III, conserved site (biogroup)

1. Drug target sets for approved compounds
2. Adipose tissue, adipocytes and stromal-vascular pellet cells from multiple body regions
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

There were no matches for Tyrosine-protein kinase, receptor class III, conserved site

1. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-P…